aldophosphamide has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maki, PA; Sladek, NE | 1 |
| Borch, RF; Valente, RR | 1 |
| Boyd, VL; Gallo, KA; Ishii, K; Ludeman, SM; Regan, JB; Zon, G | 1 |
3 other study(ies) available for aldophosphamide and Leukemia L 1210
| Article | Year |
|---|---|
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Topics: Aldehyde Dehydrogenase; Animals; Antineoplastic Agents; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Hematopoietic Stem Cells; Inactivation, Metabolic; Kinetics; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Phosphoramide Mustards; Procarbazine | 1991 |
Synthesis, activation, and cytotoxicity of aldophosphamide analogues.
Topics: Animals; Antineoplastic Agents; Cyclization; Hydrogen-Ion Concentration; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Phosphoramide Mustards | 1991 |
Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide.
Topics: Animals; Antineoplastic Agents; Cyanides; Cyclophosphamide; Half-Life; Hydrogen-Ion Concentration; Kinetics; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Phosphoramide Mustards | 1986 |